ALPS Medical Breakthroughs ETF
SBIO
47 hedge funds and large institutions have $44M invested in ALPS Medical Breakthroughs ETF in 2019 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 17 increasing their positions, 10 reducing their positions, and 6 closing their positions.
38,867% more call options, than puts
Call options by funds: $2.34M | Put options by funds: $6K
70% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 10
1.65% more ownership
Funds ownership: 25.41% → 27.06% (+1.6%)
0% more funds holding
Funds holding: 47 → 47 (0)
0% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 6
10% less capital invested
Capital invested by funds: $48.6M → $44M (-$4.64M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$903K |
| 2 |
Stifel Financial
St. Louis,
Missouri
|
+$836K |
| 3 |
CT
Cambridge Trust
Cambridge,
Massachusetts
|
+$737K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$683K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$519K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$2.85M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$875K |
| 3 |
MCM
Murphy Capital Management
Bedminster,
New Jersey
|
-$267K |
| 4 |
WS
Wedbush Securities
Los Angeles,
California
|
-$263K |
| 5 |
GAM
Griffin Asset Management
New York
|
-$57.6K |
SBIO Hedge Fund Activity: Q3 2019 in Review
47 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in ALPS Medical Breakthroughs ETF (SBIO) for Q3 2019, worth a combined $44M — down 9.5% from $48.6M a quarter earlier.
Fund positioning in SBIO was balanced in Q3 2019: 6 funds opened new positions, 6 closed out, 17 added to existing stakes and 10 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $903K. The largest seller was Morgan Stanley, cutting an estimated $2.85M.
- 47 institutional investors held ALPS Medical Breakthroughs ETF (SBIO) as of Q3 2019, unchanged from Q2 2019.
- Funds reported $44M of ALPS Medical Breakthroughs ETF stock for Q3 2019, down 9.5% quarter-over-quarter.
- 6 funds opened new ALPS Medical Breakthroughs ETF positions in Q3 2019 and 6 closed out, a net change of 0 holders.
- The largest ALPS Medical Breakthroughs ETF buyer in Q3 2019 was Susquehanna International Group, an estimated $903K added.
- The largest ALPS Medical Breakthroughs ETF seller in Q3 2019 was Morgan Stanley, an estimated $2.85M sold.
Based on aggregated 13F filings for Q3 2019.